Likewise, IPF patients exhibited enhanced levels of phosphorylated JAK2-STAT3 in lung tissues while dual inhibition of phosphorylated JAK2-STAT3 reduced lung fibrosis in mice with bleomycin challenge [142]. Here, STAT3 is linked to idiopathic pulmonary fibrosis.